Author: BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Microplate Reader Market Forecast to 2027 – COVID-19 Impact and Global Analysis By Type, Application, and End User” report has been added to ResearchAndMarkets.com’s offering.

According to this report the global microplat…

LOS ANGELES–(BUSINESS WIRE)–Children’s Hospital Los Angeles (CHLA) today joins in announcing the launch of a groundbreaking Children’s Hospital Coalition: Powered by Phlow™ (CHC). This first-in-kind coalition brings together some of the top children’…

DUBLIN–(BUSINESS WIRE)–The “ST266 – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.

ST266 is a non-cellular biologic drug candidate, currently considered “investigational,” since it is not yet…

DUBLIN–(BUSINESS WIRE)–The “ST266 – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.

ST266 is a non-cellular biologic drug candidate, currently considered “investigational,” since it is not yet…

DUBLIN–(BUSINESS WIRE)–The “ADV7103 – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.

ADV7103 is an investigational drug designed to treat distal renal tubular acidosis (dRTA) in patients of a…

DUBLIN–(BUSINESS WIRE)–The “AV-101 – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.

AV-101 (4-Cl-KYN) belongs to a new generation of investigational medicines in neuropsychiatry and neurology…

DUBLIN–(BUSINESS WIRE)–The “AV-101 – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.

AV-101 (4-Cl-KYN) belongs to a new generation of investigational medicines in neuropsychiatry and neurology…

DUBLIN–(BUSINESS WIRE)–The “AV-101 – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.

AV-101 (4-Cl-KYN) belongs to a new generation of investigational medicines in neuropsychiatry and neurology…

DUBLIN–(BUSINESS WIRE)–The “AV-101 – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.

AV-101 (4-Cl-KYN) belongs to a new generation of investigational medicines in neuropsychiatry and neurology…

DUBLIN–(BUSINESS WIRE)–The “REL-1017 – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.

REL-1017 acts as NMDA receptor antagonists and is being developed Relmada Therapeutics. The U.S. Food and…